OSL oncosil medical ltd

Ann: Letter to Short Dated Option Holders, page-8

  1. 6,553 Posts.
    lightbulb Created with Sketch. 252
    in the financial year that just ended ( 2024 ) Oncosil's revenue doubles every quarter, leading us to believe it might increase again in Q4; if it continues after that we will soon have revenue similar to TLX in 2019, Q3 and Q4. Market cap would grow rather quickly at that time for Telix. -

    We might be witnessing a similar development at the moment with Oncosil, albeit the early stages! ( Always do your own research and ask your financial adviser)

    https://hotcopper.com.au/data/attachments/6309/6309752-2e9035c5b9a87ee14b289e802745ad69.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.09
Change
-0.020(1.80%)
Mkt cap ! $20.51M
Open High Low Value Volume
$1.11 $1.12 $1.08 $19.98K 18.08K

Buyers (Bids)

No. Vol. Price($)
3 3196 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 3598 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.